← Leaderboards
Geeta Upadhyay
Georgetown University
$2,703,109
Attributed
$2,703,109
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $613.1K · FY2014–22$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,703,109 · 3
By mechanism
R01$1,942,533 · 1
R21$760,576 · 2
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Kevin J Cullen$20,041,785
- Laura Rozek$5,698,652
- Radoslav Goldman$15,613,842
- David Alastair Flockhart$24,746,163
- Robert R. Clarke$13,679,896
Others in their field
Top investigators on “Cancer Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$394,493,843
- Gregory H Reaman · National Childhood Cancer Foundation$172,801,935
- Richard A Gibbs · Baylor College Of Medicine$159,160,442
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary M Horowitz · Medical College Of Wisconsin$153,900,671
- William George Nelson · Johns Hopkins University$111,434,918
Research focus
Cancer CellAffectSignal TransductionBiological MarkersTriple-Negative Invasive Breast CarcinomaNormal CellNew Therapeutic TargetOverexpressionTumorMalignant Breast NeoplasmMouse ModelGrowthCellsMalignant NeoplasmsBreast Cancer CellImmuneMalignant Stomach NeoplasmHead CancerMalignant Neoplasm Of OvaryEpithelial To Mesenchymal TransitionKnock-DownCell Surface ProteinsFemaleKnockout Mice
Grant awards (9)
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer$388,498
R01 · FY2022 · CA · contact PI
Use of Ly6K specific CAR T-cells to treat primary and metastatic triple negative breast cancer$174,666
R21 · FY2022 · CA · contact PI
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer$399,241
R01 · FY2021 · CA · contact PI
Use of Ly6K specific CAR T-cells to treat primary and metastatic triple negative breast cancer$213,876
R21 · FY2021 · CA · contact PI
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer$398,541
R01 · FY2020 · CA · contact PI
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer$389,208
R01 · FY2019 · CA · contact PI
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer$367,045
R01 · FY2018 · CA · contact PI
Role of Ly6 genes in estrogen receptor positive and negative breast cancer$169,106
R21 · FY2015 · CA · contact PI
Role of Ly6 genes in estrogen receptor positive and negative breast cancer$202,928
R21 · FY2014 · CA · contact PI